ArticleTheranostics2020
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 44 citations in OpenAlex.
- 3D co-culture model of tumor spheroid and endothelial cells unveils ccRCC aberrant vasculature and distinct sensitivity to targeted treatments.Angiogenesis · 2026Article
- Primary Cilium Forces Neuroendocrine Shift in Prostate Cancer through YAP1 Repression and Reduced Mitochondrial Activity.Theranostics · 2026Article
- A histone acetylation score for prognostic stratification and immunogenomic profiling in esophageal cancer.Discover oncology · 2025Article
- A type of pancreatic cancer cells form cell clusters from a solitary condition in a primary ciliogenesis-dependent manner.Medical molecular morphology · 2025Article
- Review
- HIF2α drives ccRCC metastasis through transcriptional activation of methylation-controlled J protein and enhanced prolegumain secretion.Cell death & disease · 2025Article
- Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC.Cell death & disease · 2024Article
- G6PD maintains the VSMC synthetic phenotype and accelerates vascular neointimal hyperplasia by inhibiting the VDAC1-Bax-mediated mitochondrial apoptosis pathway.Cellular & molecular biology letters · 2024Article
- DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications.European journal of medical research · 2024Article
- Primary cilia-associated signalling in squamous cell carcinoma of head and neck region.Frontiers in oncology · 2024Review
- The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment.Cell death & disease · 2023Article
- Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker.Disease markers · 2022Article
- Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma.Molecular therapy. Nucleic acids · 2021Article
- A role for primary cilia in coral calcification?Cell and tissue research · 2021Article
- Evidences of a Direct Relationship between Cellular Fuel Supply and Ciliogenesis Regulated by Hypoxic VDAC1-ΔC.Cancers · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 13 institutions in 3 countries.
Lucilla FabbriUniversité Côte d'Azur (UCA), CNRS-UMR 7284-Inserm U1081, IRCAN, Centre Antoine Lacassagne, 33 Ave. de Valombrose, 06189 Nice, France.
Maeva DufiesMedical Biology Department, Centre Scientifique de Monaco (CSM), Monaco.
Sandra Lacas-GervaisUniversité Côte d'Azur (UCA), Centre Commun de Microscopie Appliquée, Nice, France.
Betty GardieInstitut du thorax, INSERM, CNRS, Univ. Nantes, Nantes, France.
Sophie Gad-LapiteauINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, PSL, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, 114 rue Edouard Vaillant, 94800 Villejuif, France.
Julien ParolaUniversité Côte d'Azur (UCA), CNRS-UMR 7284-Inserm U1081, IRCAN, Centre Antoine Lacassagne, 33 Ave. de Valombrose, 06189 Nice, France.
Nicolas NottetPresent address: Université Côte d'Azur (UCA), INSERM U1065, C3M, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice Cedex 03, France.
Monique Meyenberg Cunha de PaduaPresent address: Université Côte d'Azur (UCA), INSERM U1065, C3M, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice Cedex 03, France.
Julie ContentiPresent address: Université Côte d'Azur (UCA), INSERM U1065, C3M, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice Cedex 03, France.
Delphine BorchielliniCentre Antoine Lacassagne, Oncology Department, Nice, France.
Jean-Marc FerreroPresent address: Université Côte d'Azur (UCA), INSERM U1065, C3M, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice Cedex 03, France.
Nathalie Rioux LeclercqRennes University, Rennes University Hospital, Department of Pathology, Rennes, France.
Damien AmbrosettiCentre Hospitalier Universitaire de Nice, Department of Pathology, Nice, France.
Baharia MograbiUniversité Côte d'Azur (UCA), CNRS-UMR 7284-Inserm U1081, IRCAN, Centre Antoine Lacassagne, 33 Ave. de Valombrose, 06189 Nice, France.
Stéphane RichardINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, PSL, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, 114 rue Edouard Vaillant, 94800 Villejuif, France.
Julien ViottiCentre Antoine Lacassagne, Statistics Department, Nice, France.
Emmanuel ChamoreyCentre Antoine Lacassagne, Statistics Department, Nice, France.
Nirvana SadaghianlooUniversité Côte d'Azur (UCA), CNRS-UMR 7284-Inserm U1081, IRCAN, Centre Antoine Lacassagne, 33 Ave. de Valombrose, 06189 Nice, France.
Matthieu RouleauUniversité Côte d'Azur (UCA), CNRS-UMR 7370, LP2M, Nice, France.
William J CraigenDepartment of Molecular and Human Genetics, The Mitochondrial Diagnostic Laboratory, Baylor College of Medicine, Houston, TX 77030, USA.
Bernard MariUniversité Côte d'Azur (UCA), CNRS, IPMC, FHUOncoAge, 06560 Valbonne, France.
Stéphan ClavelPresent address: Université Côte d'Azur (UCA), INSERM U1065, C3M, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice Cedex 03, France.
Gilles PagèsUniversité Côte d'Azur (UCA), CNRS-UMR 7284-Inserm U1081, IRCAN, Centre Antoine Lacassagne, 33 Ave. de Valombrose, 06189 Nice, France.
Jacques PouysségurUniversité Côte d'Azur (UCA), CNRS-UMR 7284-Inserm U1081, IRCAN, Centre Antoine Lacassagne, 33 Ave. de Valombrose, 06189 Nice, France.
Frédéric BostPresent address: Université Côte d'Azur (UCA), INSERM U1065, C3M, 151 Route de St Antoine de Ginestière, BP2 3194, 06204 Nice Cedex 03, France.
Nathalie M MazureUniversité Côte d'Azur (UCA), CNRS-UMR 7284-Inserm U1081, IRCAN, Centre Antoine Lacassagne, 33 Ave. de Valombrose, 06189 Nice, France.
Centre Antoine Lacassagne · FRCentre Méditerranéen de Médecine Moléculaire · FRInstitut de Recherche sur le Cancer et le Vieillissement de Nice · FRScientific Centre of Monaco · MCAssistance Publique – Hôpitaux de Paris · FRBaylor College of Medicine · USCentre Hospitalier Universitaire de Nice · FRCentre National de la Recherche Scientifique · FRInstitut de Biologie Valrose · FRInstitut du Thorax · FRInstitut Gustave Roussy · FRLaboratoire de PhysioMédecine Moléculaire · FRUniversité de Rennes · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Renal CellCiliaKidney NeoplasmsAdultAgedAged, 80 and overCell Line, TumorCohort StudiesEpithelial-Mesenchymal TransitionFemaleHumansMaleMiddle AgedVoltage-Dependent Anion Channel 1Von Hippel-Lindau Tumor Suppressor ProteinYoung AdultVDAC1 protein, humanVHL protein, humanVoltage-Dependent Anion Channel 1Von Hippel-Lindau Tumor Suppressor ProteinCiliopathyclear cell Renal Cell CarcinomaHIFsimmunotherapypoor prognosisprimary ciliumVDAC1.Voltage-Dependent Anion Channel 1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.